Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Bone Marrow Transplant. 2010 Sep 6;46(6):813–819. doi: 10.1038/bmt.2010.210

Table 5.

Primary diagnoses of Group 1 (N = 107) and patients who had ON before alloBMT (n = 23)

Primary Diagnosis Group 1
[n (%)]		 Patients with ON
[n (%)]
Malignant Conditions 89 (83.17) 19 (82.60)
Lymphoid Malignancies
 ALL 39 (36.45) 10 (43.48)
 NHL 2 (1.87) 0 (0)
 Hodgkin Disease 1 (0.93) 1 (4.35)
Nonlymphoid Malignancies
 AML/MDS 33 (30.84) 5 (21.74)
 CML 9 (8.41) 2 (8.7)
 Sarcoma 5 (4.67) 1 (4.35)
Nonmalignant Conditions 18 (16.82) 4 (17.4)
 Sickle cell disease 12 (11.21) 2 (8.7)
 Aplastic anemia 3 (2.80) 2 (8.70)
 Duncan syndrome 1 (0.93) 0 (0)
 Hemophagocytic
 lymphohistiocytosis		 1 (0.93) 0 (0)
 Hyper–Ig M Syndrome 1 (0.93) 0 (0)

Abbreviations: ALL, acute lymphoid leukemia; AML/MDS, acute myeloid leukemia and myelodysplastic syndrome; CML, chronic myeloid leukemia; NHL, non-Hodgkin lymphoma.